By Steve Deane 5:00 AM Monday Feb 9, 2015 nzherald.co.nz
Pre-gym supplement Frenzy banned in NZ after it is found to contain psychoactive substance
Health Ministry of Health Sport
The Herald's undercover investigation into pre-workout supplements
An exercise supplement containing a substance not considered safe for human use will be pulled from New Zealand shelves following a Herald investigation.
Testing performed by the Institute of Environmental Science and Research (ESR) indicated the pre-workout supplement Frenzy contains the banned psychoactive substance DMBA, a chemical cousin of a party-pill ingredient whose effects have been studied only in cats and dogs.
Pre-workout supplements are designed to boost energy and concentration during gym workouts. They are hugely popular despite a rash of recent cases where products have been found to contain illegal and dangerous substances such as methamphetamine analogues, banned stimulants and psychoactive agents..read more
The hottest new additions to the stimulant ingredient market in 2015 is a compound commonly known as DMBA HCL. Also known as AMP HCL, 1,3-dimethylbutylamine HCL or 2-amino-4-methylpentane HCL, this compound a potential alternative to the now banned and once popular DMAA In 2012, the Food and Drug Administration banned DMAA because of reports of its side effects, including heart problems, nervous system disorders and even death.
DMBA was found in 12 weight loss and sports supplements, some of which are sold in mainstream shops, according to a new study October 08, 2014.
One of the products in the study is a powder called Frenzy, which is described by retailers as the sequel to a product called Craze. Last year, studies found that Craze contained undisclosed methamphetamine-like compounds. Driven Sports, the manufacturer of Frenzy and Craze, received a warning letter regarding Craze from the FDA in April
Now, Craze is off the shelves, but Frenzy is still sold in Europe. The supplement gives consumers "endless energy," "extreme focus" and "tunnel vision," according to online comments from consumers, many of whom described the effects of Frenzy as very similar to those of Craze
Compare to DMAA, 1,3-DimethylButylamine citrate (4 amino-2-Methylpentane citrate) has very similar uses and benefits as: Attention deficit-hyperactive disorder (ADHD), to lost weight, for body building...etc. However it has very few side effect that cause health problems to human body, which makes 1,3-DimethylButylamine citrate (4 amino-2-Methylpentane citrate) becoming an new popular supplement products in supplement market.
pecial Precautions & Warnings:
Pregnancy and breast-feeding: Not enough is known about the use of 1,3-DimethylButylamine citrate (4 amino-2-Methylpentane citrate) during pregnancy and breast-feeding. Stay on the safe side and avoid use.
By Cpl. Mary Carmona
Published: Thursday, January 22, 2015 at 11:23 AM.
Supplement products containing 1, 3-dimethylbutylamine (DMBA) were recently pulled from all Exchange, GNC and Vitamin World stores aboard military bases.
The synthetic stimulant is found in more than a dozen products, ranging from workout to weight loss supplements. It has multiple aliases, such as AMP citrate and 4-methyl-2-pentanamine.
DMBA has never been tested in humans and is extremely similar to DMAA, a stimulant banned by the U.S. Food and Drug Administration in April 2013.
DMAA is linked to health problems such as cardiovascular disease and nervous system disorders; it has even been called into question in multiple deaths.
more at http://www.jdnews.com/news/military/dmba-products-pulled-from-on-base-stores-1.428066
DMBA workout stimulant pulled from base shelves
http://pt365.militarytimes.com/2014/10/29/dmba-workout-stimulant-pulled-from-base-shelves/tober 29, 2014
Study warns about stimulants in diet supplements
The study, published in the peer-reviewed journal Drug Testing and Analysis Thursday, concluded 12 out of 14 tested supplements for weight loss, workouts and brain enhancement contain "AMP Citrate," or DMBA.
Scientists say it's a chemical cousin to an ingredient banned by the Food and Drug Administration.
"It's similar to amphetamines, which have cardiac and neuropsychiatric effects, and it is a cousin to a stimulant called DMAA that was pulled from the market in 2012 for having 86 adverse events recorded that include heart attack, stroke, seizure and death," CBS News medical contributor Dr. Tara Narula, a cardiologist at Lenox Hill Hospital in New York City, said on "CBS This Morning.